Maze Therapeutics' Key Advances in Chronic Kidney Disease Therapies
Explore Maze Therapeutics' progress with MZE829 and MZE782, innovative treatments targeting chronic kidney disease. Learn more about these leading programs.
Maze Therapeutics is advancing two lead programs, MZE829 and MZE782, for chronic kidney disease.